4/17
08:10 am
lipo
Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise [Yahoo! Finance]
Low
Report
Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise [Yahoo! Finance]
4/17
08:00 am
lipo
Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise
Low
Report
Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise
4/9
12:09 pm
lipo
Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) is now covered by analysts at Maxim Group. They set a "buy" rating and a $2.00 price target on the stock.
Low
Report
Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) is now covered by analysts at Maxim Group. They set a "buy" rating and a $2.00 price target on the stock.
4/5
08:08 am
lipo
Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024 [Yahoo! Finance]
Medium
Report
Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024 [Yahoo! Finance]
4/5
08:00 am
lipo
Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024
Medium
Report
Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024
4/3
08:24 am
lipo
Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis [Yahoo! Finance]
Medium
Report
Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis [Yahoo! Finance]
4/3
08:00 am
lipo
Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis
Low
Report
Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis
3/7
03:23 pm
lipo
PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease
Medium
Report
PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease
5/9
04:08 pm
lipo
Form 10-Q LIPELLA PHARMACEUTICALS For: Mar 31
Low
Report
Form 10-Q LIPELLA PHARMACEUTICALS For: Mar 31
5/6
04:06 pm
lipo
Form SC 13D/A LIPELLA PHARMACEUTICALS Filed by: Kaufman Jonathan H
Low
Report
Form SC 13D/A LIPELLA PHARMACEUTICALS Filed by: Kaufman Jonathan H
4/19
04:15 pm
lipo
Form 8-K LIPELLA PHARMACEUTICALS For: Apr 19
Low
Report
Form 8-K LIPELLA PHARMACEUTICALS For: Apr 19
4/12
04:16 pm
lipo
Form 8-K LIPELLA PHARMACEUTICALS For: Apr 12
Medium
Report
Form 8-K LIPELLA PHARMACEUTICALS For: Apr 12
3/19
06:27 pm
lipo
Form 4 LIPELLA PHARMACEUTICALS For: Mar 15 Filed by: Pruchnic Ryan
Medium
Report
Form 4 LIPELLA PHARMACEUTICALS For: Mar 15 Filed by: Pruchnic Ryan
3/19
06:25 pm
lipo
Form 4 LIPELLA PHARMACEUTICALS For: Mar 15 Filed by: Yoshimura Naoki
Medium
Report
Form 4 LIPELLA PHARMACEUTICALS For: Mar 15 Filed by: Yoshimura Naoki
3/19
06:24 pm
lipo
Form 4 LIPELLA PHARMACEUTICALS For: Mar 15 Filed by: Chancellor Michael B
Medium
Report
Form 4 LIPELLA PHARMACEUTICALS For: Mar 15 Filed by: Chancellor Michael B
3/19
06:23 pm
lipo
Form 4 LIPELLA PHARMACEUTICALS For: Mar 15 Filed by: Birder Lori
Medium
Report
Form 4 LIPELLA PHARMACEUTICALS For: Mar 15 Filed by: Birder Lori
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register